Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Cash from Investing Activities (2023 - 2025)

Contineum Therapeutics has reported Cash from Investing Activities over the past 3 years, most recently at -$47.5 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$47.5 million for Q4 2025, down 405.46% from a year ago — trailing twelve months through Dec 2025 was -$3.7 million (up 94.68% YoY), and the annual figure for FY2025 was -$3.7 million, up 94.68%.
  • Cash from Investing Activities for Q4 2025 was -$47.5 million at Contineum Therapeutics, down from $14.9 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for CTNM hit a ceiling of $14.9 million in Q3 2025 and a floor of -$47.5 million in Q4 2025.
  • Median Cash from Investing Activities over the past 3 years was -$328500.0 (2024), compared with a mean of -$11.6 million.
  • Peak annual rise in Cash from Investing Activities hit 149.5% in 2025, while the deepest fall reached 405.46% in 2025.
  • Contineum Therapeutics' Cash from Investing Activities stood at $9.0 million in 2023, then tumbled by 203.96% to -$9.4 million in 2024, then crashed by 405.46% to -$47.5 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$47.5 million (Q4 2025), $14.9 million (Q3 2025), and $13.9 million (Q2 2025) per Business Quant data.